Frazier Lifesciences Acquisition Corporation Unit
FLACU
FLACU was delisted on the 22nd of November, 2022.
37 hedge funds and large institutions have $64.6M invested in Frazier Lifesciences Acquisition Corporation Unit in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 38 closing their positions.
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
48% less capital invested
Capital invested by funds: $124M → $64.6M (-$59.2M)
48% less funds holding
Funds holding: 71 → 37 (-34)
89% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$799K |
| 2 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$742K |
| 3 |
MTCM
Mint Tower Capital Management
Amsterdam,
Netherlands
|
+$206K |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$140K |
| 5 |
HF
HRT Financial
New York
|
+$125K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$7.42M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$5.73M |
| 3 |
DCM
DG Capital Management
New York
|
-$4.68M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$4.3M |
| 5 |
GL
Governors Lane
New York
|
-$4.15M |
FLACU Hedge Fund Activity: Q1 2021 in Review
37 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Unit (FLACU) for Q1 2021, worth a combined $64.6M — down 48% from $124M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of FLACU and 4 opened new positions — a net loss of 34 holders — while 9 trimmed existing stakes and 8 added.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $799K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $7.42M sold.
- 37 institutional investors held Frazier Lifesciences Acquisition Corporation Unit (FLACU) as of Q1 2021, down from 71 in Q4 2020.
- Funds reported $64.6M of Frazier Lifesciences Acquisition Corporation Unit stock for Q1 2021, down 48% quarter-over-quarter.
- 4 funds opened new Frazier Lifesciences Acquisition Corporation Unit positions in Q1 2021 and 38 closed out, a net change of -34 holders.
- The largest Frazier Lifesciences Acquisition Corporation Unit buyer in Q1 2021 was Ikarian Capital, an estimated $799K added.
- The largest Frazier Lifesciences Acquisition Corporation Unit seller in Q1 2021 was Alyeska Investment Group, an estimated $7.42M sold.
Based on aggregated 13F filings for Q1 2021.